Viveve Medical, Inc.
Other OTCTotal Valuation
Viveve Medical, Inc. carries a market capitalization of 2,145.00, placing it among publicly traded companies globally. Its enterprise value stands at 72.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2,145.00 |
| Enterprise Value | 72.37B |
Share Statistics
Viveve Medical, Inc. currently has 10.70M shares outstanding.
| Shares Outstanding | 10.70M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 10,601.56, and the price-to-book ratio stands at -279.93.
| PE Ratio | N/A |
| PS Ratio | 10,601.56 |
| PB Ratio | -279.93 |
| P/TBV Ratio | 61,120.15 |
| P/FCF Ratio | -4,627.89 |
| P/OCF Ratio | -4,458.25 |
Enterprise Valuation
| EV / Sales | 10,601.56 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Viveve Medical, Inc. maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 496.71, indicating elevated leverage, while an interest coverage ratio of -18.29 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.89 |
| Quick Ratio | 0.62 |
| Debt / Equity | 496.71 |
| Debt / EBITDA | -0.29 |
| Interest Coverage | -18.29 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -108.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.03 |
Stock Price Statistics
Viveve Medical, Inc.'s stock has gained approximately 100.00001% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 100.00001% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Viveve Medical, Inc. generated 6.83M in revenue and converted that into -22.99M in net income, yielding earnings per share of -2.16. EBITDA reached -20.34M, while operating income came in at -21.14M.
| Revenue | 6.83M |
| Gross Profit | 1.12M |
| Operating Income | -21.14M |
| Pretax Income | -22.34M |
| Net Income | -22.99M |
| EBITDA | -20.34M |
| EBIT | -21.14M |
| Earnings Per Share (EPS) | -2.16 |
Balance Sheet
Viveve Medical, Inc. holds 5.91M in cash and equivalents against 5.88M in total debt, resulting in a net debt position of -279,000.00. Total book value stands at -258.51M, with working capital of -1.23M providing operational flexibility.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | 5.88M |
| Net Debt | -279,000.00 |
| Equity (Book Value) | -258.51M |
| Book Value Per Share | -24.29 |
| Working Capital | -1.23M |
Cash Flow
Viveve Medical, Inc. produced -16.23M in operating cash flow over the past twelve months. After subtracting -595,000.00 in capital expenditures, free cash flow totaled -16.83M - equivalent to -1.58 per share.
| Operating Cash Flow | -16.23M |
| Capital Expenditures | -595,000.00 |
| Free Cash Flow | -16.83M |
| FCF Per Share | -1.58 |
Margins
Viveve Medical, Inc. operates with a gross margin of 16.39, reflecting its pricing power and cost economics. The operating margin of -309.73 and net profit margin of -336.79 provide insight into operational efficiency.
| Gross Margin | 16.39 |
| Operating Margin | -309.73 |
| Pretax Margin | -327.34 |
| Profit Margin | -336.79 |
| EBITDA Margin | -297.92 |
Dividends & Yields
The company's payout ratio of 18.41 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 18.41 |
| Shareholder Yield | 0.00 |
| FCF Yield | -0.02 |
Stock Splits
Viveve Medical, Inc.'s most recent stock split took place on December 2, 2020 with a 10:1 split ratio.
| Last Split Date | 12/2/2020 |
| Split Ratio | 10:1 |
Scores
Viveve Medical, Inc. posts an Altman Z-Score of 3,922.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3,922.97 |